Moderna
MRNA
23,06 €
Share price
6.94%
Change (1 day)
-76.48%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: €8.91 Billion
As of April 2025 Moderna has a market cap of €8.91 Billion. This makes Moderna the world's 1591th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €8.91 B | -39.93% |
| 2024 | €14.84 B | -56.74% |
| 2023 | €34.30 B | -46.68% |
| 2022 | €64.33 B | -29.25% |
| 2021 | €90.92 B | 170.54% |
| 2020 | €33.60 B | 471.97% |
| 2019 | €5.87 B | 33.89% |
| 2018 | €4.38 B |
End of Day market cap according to different sources
On Apr 11th, 2025 the market cap of Moderna was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | €0.10 B | -98.84% | 🇺🇸 USA |
 | €175.33 B | 1,867.00% | 🇺🇸 USA |
 | €0.73 M | -99.99% | 🇺🇸 USA |
 | €27.08 B | 203.80% | 🇺🇸 USA |
 | €186.87 B | 1,996.46% | 🇨🇭 Switzerland |
 | €1.42 B | -84.02% | 🇺🇸 USA |
 | €321.76 B | 3,509.71% | 🇺🇸 USA |
 | €2.62 B | -70.60% | 🇺🇸 USA |